• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Polymorphism in the PAI-1 (SERPINE1) gene and the risk of osteonecrosis in children with acute lymphoblastic leukemia.

作者信息

Bond Jonathan, Adams Stuart, Richards Susan, Vora Ajay, Mitchell Christopher, Goulden Nicholas

出版信息

Blood. 2011 Sep 1;118(9):2632-3. doi: 10.1182/blood-2011-05-355206.

DOI:10.1182/blood-2011-05-355206
PMID:21885611
Abstract
摘要

相似文献

1
Polymorphism in the PAI-1 (SERPINE1) gene and the risk of osteonecrosis in children with acute lymphoblastic leukemia.纤溶酶原激活物抑制剂-1（SERPINE1）基因多态性与急性淋巴细胞白血病患儿的骨坏死风险
Blood. 2011 Sep 1;118(9):2632-3. doi: 10.1182/blood-2011-05-355206.
2
A PAI-1 (SERPINE1) polymorphism predicts osteonecrosis in children with acute lymphoblastic leukemia: a report from the Children's Oncology Group.一种纤溶酶原激活物抑制剂-1（SERPINE1）基因多态性可预测急性淋巴细胞白血病患儿的骨坏死：来自儿童肿瘤协作组的报告。
Blood. 2008 May 1;111(9):4496-9. doi: 10.1182/blood-2007-11-123885. Epub 2008 Feb 19.
3
Genetic polymorphism of vitamin D receptors and plasminogen activator inhibitor-1 and osteonecrosis risk in childhood acute lymphoblastic leukemia.维生素 D 受体和纤溶酶原激活物抑制剂-1 的遗传多态性与儿童急性淋巴细胞白血病的骨坏死风险。
Mol Genet Genomic Med. 2021 Jul;9(7):e1700. doi: 10.1002/mgg3.1700. Epub 2021 May 27.
4
Asparaginase combined with discontinuous dexamethasone improves antileukemic efficacy without increasing osteonecrosis in preclinical models. asparaginase 联合间断地塞米松治疗可提高临床前模型的抗白血病疗效，而不增加骨坏死。
PLoS One. 2019 May 6;14(5):e0216328. doi: 10.1371/journal.pone.0216328. eCollection 2019.
5
Osteonecrosis as a complication of treating acute lymphoblastic leukemia in children: a report from the Children's Cancer Group.儿童急性淋巴细胞白血病治疗并发症——骨坏死：儿童癌症研究组报告
Clin Pediatr (Phila). 2002 Jan-Feb;41(1):63-4. doi: 10.1177/000992280204100114.
6
Assessment of corticosteroid-induced osteonecrosis in children undergoing chemotherapy for acute lymphoblastic leukemia: a report from the Japanese Childhood Cancer and Leukemia Study Group.急性淋巴细胞白血病化疗儿童中皮质类固醇诱导性骨坏死的评估：来自日本儿童癌症与白血病研究组的报告
J Pediatr Hematol Oncol. 2014 Jan;36(1):22-9. doi: 10.1097/MPH.0000000000000039.
7
Severe hypertriglyceridaemia during therapy for childhood acute lymphoblastic leukaemia.儿童急性淋巴细胞白血病治疗期间的严重高甘油三酯血症
Eur J Cancer. 2014 Oct;50(15):2685-94. doi: 10.1016/j.ejca.2014.06.023. Epub 2014 Jul 30.
8
Avascular necrosis--an antineoplastic-treatment-related toxicity: the experiences of two institutions.缺血性坏死——一种与抗肿瘤治疗相关的毒性反应：两家机构的经验
Pediatr Hematol Oncol. 2006 Dec;23(8):625-9. doi: 10.1080/08880010600909938.
9
Effect of alternate-week versus continuous dexamethasone scheduling on the risk of osteonecrosis in paediatric patients with acute lymphoblastic leukaemia: results from the CCG-1961 randomised cohort trial.交替周与连续地塞米松方案对急性淋巴细胞白血病患儿发生骨坏死风险的影响：来自 CCG-1961 随机队列试验的结果。
Lancet Oncol. 2012 Sep;13(9):906-15. doi: 10.1016/S1470-2045(12)70274-7. Epub 2012 Aug 15.
10
Osteonecrosis as a complication of treating acute lymphoblastic leukemia in children: a report from the Children's Cancer Group.儿童急性淋巴细胞白血病治疗并发症——骨坏死：儿童癌症研究组报告
J Clin Oncol. 2000 Sep 15;18(18):3262-72. doi: 10.1200/JCO.2000.18.18.3262.

引用本文的文献

1
Prevalence of Osteonecrosis in Survivors of Childhood Acute Lymphoblastic Leukaemia of Indian Ethnicity Treated with BFM Protocol.采用BFM方案治疗的印度裔儿童急性淋巴细胞白血病幸存者中骨坏死的患病率
Indian J Hematol Blood Transfus. 2025 Apr;41(2):320-326. doi: 10.1007/s12288-024-01861-4. Epub 2024 Sep 5.
2
Mesenchymal stem cell-derived extracellular vesicles: a possible therapeutic strategy for orthopaedic diseases: a narrative review.间充质干细胞衍生的细胞外囊泡：一种治疗骨科疾病的可能策略：叙述性综述
Biomater Transl. 2022 Sep 28;3(3):175-187. doi: 10.12336/biomatertransl.2022.03.002. eCollection 2022.
3
Osteonecrosis in Korean Paediatric and Young Adults with Acute Lymphoblastic Leukaemia or Lymphoblastic Lymphoma: A Nationwide Epidemiological Study.
韩国儿童和年轻成人急性淋巴细胞白血病或淋巴细胞淋巴瘤患者的骨坏死：一项全国性流行病学研究。
J Clin Med. 2022 Apr 28;11(9):2489. doi: 10.3390/jcm11092489.
4
Genetic polymorphism of vitamin D receptors and plasminogen activator inhibitor-1 and osteonecrosis risk in childhood acute lymphoblastic leukemia.维生素 D 受体和纤溶酶原激活物抑制剂-1 的遗传多态性与儿童急性淋巴细胞白血病的骨坏死风险。
Mol Genet Genomic Med. 2021 Jul;9(7):e1700. doi: 10.1002/mgg3.1700. Epub 2021 May 27.
5
Bone marrow mesenchymal stem cell-derived exosomes promote plasminogen activator inhibitor 1 expression in vascular cells in the local microenvironment during rabbit osteonecrosis of the femoral head.骨髓间充质干细胞来源的外泌体在兔股骨头坏死局部微环境中促进血管细胞中纤溶酶原激活物抑制剂 1 的表达。
Stem Cell Res Ther. 2020 Nov 11;11(1):480. doi: 10.1186/s13287-020-01991-2.
6
Association between genetic polymorphisms and osteonecrosis in steroid treatment populations: a detailed stratified and dose-response meta-analysis.遗传多态性与类固醇治疗人群骨坏死的关系：详细分层和剂量反应荟萃分析。
Biosci Rep. 2019 May 14;39(5). doi: 10.1042/BSR20190024. Print 2019 May 31.
7
Lipid Transporter Activity-Related Genetic Polymorphisms Are Associated With Steroid-Induced Osteonecrosis of the Femoral Head: An Updated Meta-Analysis Based on the GRADE Guidelines.脂质转运蛋白活性相关基因多态性与类固醇性股骨头坏死相关：基于GRADE指南的最新荟萃分析
Front Physiol. 2018 Dec 3;9:1684. doi: 10.3389/fphys.2018.01684. eCollection 2018.
8
Skeletal Morbidity in Children and Adolescents during and following Cancer Therapy.儿童和青少年癌症治疗期间和治疗后的骨骼发病率。
Horm Res Paediatr. 2019;91(2):137-151. doi: 10.1159/000494809. Epub 2018 Nov 27.
9
Association between plasminogen activator inhibitor gene polymorphisms and osteonecrosis of the femoral head susceptibility: A case-control study.纤溶酶原激活物抑制剂基因多态性与股骨头坏死易感性的关联：一项病例对照研究。
Medicine (Baltimore). 2017 Oct;96(42):e7047. doi: 10.1097/MD.0000000000007047.
10
Pharmacogenetic Predictors of Treatment-Related Toxicity Among Children With Acute Lymphoblastic Leukemia.急性淋巴细胞白血病患儿治疗相关毒性的药物遗传学预测指标
Curr Hematol Malig Rep. 2017 Jun;12(3):176-186. doi: 10.1007/s11899-017-0376-z.